Abbas, Hadjan M.
HRN: 18-68-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFTAZIDIME 1GM (VIAL)
05/06/2022
05/12/2022
IV
1 Gm
Q8H
T/C PTB Relapse; CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes